UNESCO | Chair in Bioethics and Human Rights Revenue and Competitors

Atlanta, GA USA

Location

N/A

Total Funding

Arts

Industry

Employee Data

  • UNESCO | Chair in Bioethics and Human Rights has 47 Employees.(i)
  • UNESCO | Chair in Bioethics and Human Rights grew their employee count by 0% last year.

UNESCO | Chair in Bioethics and Human Rights's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15M2408%N/AN/A
#2
$35M1428%N/AN/A
#3
$7.5M1272%N/AN/A
#4
$1.7M602%N/AN/A
#5
N/A1376%N/AN/A
#6
N/A470%N/AN/A
#7
N/A274%N/AN/A
#8
$15M1093%N/AN/A
#9
$1.7M500%N/AN/A
#10
N/A625%N/AN/A
Add Company

What Is UNESCO | Chair in Bioethics and Human Rights?

When we refer to behavior and conduct involved in science and technology in the field of Life Science, it is Bioethics. The UNESCO (United Nations Education, Science, and Cultural Organization) Chair in Bioethics and Human Rights seeks to promote those universal values inherent in all cultures regarding goodness, truth and beauty; to ensure the effective protection of human dignity and fundamental rights; and to stimulate greater interest, social sensitivity, compassion, and discussion of life science, bioethics and human rights. An artist plants the thought of goodness, truth and beauty in the viewer through a visual creation. Although artists come from diverse backgrounds, it is important to stress the convergence of the way we come together to be one. Art fosters convergence. We invite you to explore what is good and bad, to personally discover truth about humanity, to recognize the inherent dignity of the vulnerable, and to capture the beauty of good behavior. We invite you to create art that deepens appreciation of human life—where Art and Bioethics meet. This is our challenge to you, Artists of the Globe.

keywords:N/A

N/A

Total Funding

47

Number of Employees

N/A

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$9.6M477%$76M
#2
$5.6M47-2%N/A
#3
$5.6M4731%N/A
#4
$4.5M470%N/A
#5
$5.5M47-48%N/A